-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Intra-Cellular Therapies, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from Q2 2013 to 2024.
- Intra-Cellular Therapies, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2024 was -$34.1M, a 43.2% increase year-over-year.
- Intra-Cellular Therapies, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$73.2M, a 41.1% increase from 2023.
- Intra-Cellular Therapies, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$124M, a 54% increase from 2022.
- Intra-Cellular Therapies, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$270M, a 4.1% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)